Background & Aims Gastrointestinal (GI) manifestations have been increasingly reported in
patients with coronavirus disease 2019 (COVID-19). However, the roles of the GI tract in …

Abstract Background And Aims Besides prominent respiratory involvement, gastrointestinal
manifestations are commonly reported in Coronavirus Disease 2019 (COVID-19) patients …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent
extrapulmonary manifestation of COVID-19, we investigated intestinal infection with SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to more than
200 countries and regions globally. SARS-CoV-2 is thought to spread mainly through …

The SARS-CoV-2 pandemic has so far claimed over three and a half million lives worldwide.
Though the SARS-CoV-2 mediated disease COVID-19 has first been characterized by an …

The outbreak of novel coronavirus pneumonia in 2019 (Coronavirus disease 2019 [COVID-
19]) is now threatening global public health. Although COVID-19 is principally defined by its …

Although SARS-CoV-2 may primarily enter the cells of the lungs, the small bowel may also
be an important entry or interaction site, as the enterocytes are rich in angiotensin converting …

Coronaviruses cause several human diseases, including severe acute respiratory
syndrome. The global coronavirus disease 2019 (COVID-19) pandemic has become a huge …

Abstract The novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) has emerged and is responsible for the Coronavirus Disease 2019 global pandemic …

Exacerbated pro‐inflammatory immune response contributes to COVID‐19 pathology.
However, despite the mounting evidence about SARS‐CoV‐2 infecting the human gut, little …